Intermediate for Lesinurad. Lesinurad (trade name Zurampic) is a urate transporter (URAT1) inhibitor for treating hyperuricemia associated with gout. It received FDA approval on 22 December 2015. Lesinurad has been approved by the U.S Food and Drug Administration on 22 December 2015.
Product Name: 1-Cyclopropylnaphthalene
CAS Number: 25033-19-6
Molecular Weight:  168.2378
Molecular Formula:  C13H12
Purity (HPLC): ≥95%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.